The current and projected economic burden of Parkinson's disease in the United States

Movement Disorders

Volumn 28, Issue 3, 2013, Pages 311-318

  Kowal, Stacey L ^a   Dall, Timothy M ^a   Chakrabarti, Ritashree ^a   Storm, Michael V ^a   Jain, Anjali ^b  

^a FEKETE ASSOCIATES INC   (United States)

^b LEWIN GROUP   (United States)

Author keywords

Disease cost; Economic burden; Parkinson's disease; Parkinson's prevalence

Indexed keywords

ABSENTEEISM; ADULT; AGED; ARTICLE; CHRONIC DISEASE; DEMOGRAPHY; DISEASE MODEL; EMPLOYMENT STATUS; FEMALE; HEALTH CARE COST; HEALTH CARE UTILIZATION; HEALTH SURVEY; HUMAN; JOB PERFORMANCE; MALE; PARKINSON DISEASE; PREVALENCE; PRIORITY JOURNAL; UNITED STATES;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; COST OF ILLNESS; DISEASE PROGRESSION; FEMALE; HEALTH CARE COSTS; HEALTH SURVEYS; HUMANS; MALE; MIDDLE AGED; PARKINSON DISEASE; PREVALENCE; RETROSPECTIVE STUDIES; SEX FACTORS; TIME FACTORS; UNITED STATES;

EID: 84875543467     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.25292     Document Type: Article

References (24)

1. Noyes K, Liu H, Li Y, Holloway R, Dick AW. Economic burden associated with Parkinson's disease on elderly Medicare beneficiaries. Mov Disord 2006;21:362-372.
2. Hirtz D, Thurman DJ, Gwinn-Hardy K, Mohamed M, Chaudhuri AR, Zalutsky R. How common are the "common" neurologic disorders? Neurology 2007;68:326-337.
3. Weintraub D, Comella CL, Horn S. Parkinson's disease-Part 1: Pathophysiology, symptoms, burden, diagnosis, and assessment. Am J Manag Care 2008;14(2 Suppl):S40-S48.
4. Dorsey ER, Constantinescu R, Thompson JP, et al. Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030. Neurology 2007;68:384-386.
5. Keranen T, Kaakkola S, Sotaniemi K, et al. Economic burden and quality of life impairment increase with severity of Parkinson's disease. Parkinsonism Relat Disord 2003;9:163-168.
6. Gage H, Hendricks A, Zhang S, Kazis L. The relative health related quality of life of veterans with Parkinson's disease. J Neurol Neurosurg Psychiatry 2003;74:163-169.
7. Dowding CH, Shenton CL, Salek SS. A review of the health-related quality of life and economic impact of Parkinson's disease. Drugs Aging 2006;23:693-721.
8. Hart RG, Pearce LA, Ravina BM, Yaltho TC, Marler JR. Neuroprotection trials in Parkinson's disease: systematic review. Mov Disord 2009;24:647-654.
9. Chen JJ. Parkinson's disease: health-related quality of life, economic cost, and implications of early treatment. Am J Manag Care 2010;16(Suppl):S87-S93.
10. Huse DM, Schulman K, Orsini L, Castelli-Haley J, Kennedy S, Lenhart G. Burden of illness in Parkinson's disease. Mov Disord 2005;20:1449-1454.
11. Chrischilles EA, Rubenstein LM, Voelker MD, Wallace RB, Rodnitzky RL. The health burdens of Parkinson's disease. Mov Disord 1998;13:406-413.
12. Rubenstein LM, Chrischilles EA, Voelker MD. The impact of Parkinson's disease on health status, health expenditures, and productivity. Estimates from the National Medical Expenditure Survey. Pharmacoeconomics 1997;12:486-498.
13. Whetten-Goldstein K, Sloan F, Kulas E, Cutson T, Schenkman M. The burden of Parkinson's disease on society, family, and the individual. J Am Geriatr Soc 1997;45:844-849.
14. O'Brien JA, Ward A, Michels SL, Tzivelekis S, Brandt NJ. Economic burden associated with Parkinson disease. Drug Benefit Trends 2009;21:179-190.
15. Dodel RC, Eggert KM, Singer MS, Eichhorn TE, Pogarell O, Oertel WH. Costs of drug treatment in Parkinson's disease. Mov Disord 1998;13:249-254.
16. Bureau of Labor Statistics. All urban consumers-price index. Real earnings in January 2011. February 23, 2011. Washington, DC: Bureau of Labor and Statistics, U.S. Department of Labor. Available at: http://www.bls.gov/opub/ted/2011/ted_20110223.htm. Accessed on November 19, 2012.
17. U.S. Census. Projections of the population by selected age groups and sex for the United States: 2010 to 2050: national population projections (released 2008). January 1, 2011. Washington, DC: U.S. Census Bureau (Population Division), U.S. Department of Commerce.
18. Thanvi BR, Lo TC, Harsh DP. Psychosis in Parkinson's disease. Postgrad Med J 2005;81:644-646.
19. Social Security Administration. Monthly statistical snapshot, January 1, 2011. February 1, 2011. Washington, DC: Social Security Administration.
20. MetLife. The MetLife national survey of adult day services, January 1, 2011. September 1, 2010. New York, NY: Metropolitan Life Insurance Company.
21. Van Den Eeden SK, Tanner CM, Bernstein AL, et al. Incidence of Parkinson's disease: variation by age, gender, and race/ethnicity. Am J Epidemiol 2003;157:1015-1022.
22. Bower JH, Maraganore DM, McDonnell SK, Rocca WA. Incidence and distribution of parkinsonism in Olmsted County, Minnesota, 1976-1990. Neurology 1999;52:1214-1220.
23. National Institue of Health. Parkinson's disease: challenges, progress, and promise, October 2, 2004. December 1, 2010. Bethesda, MD: National Institutes of Health, U.S. Department of Health and Human Services.
24. Willis AW, Schootman M, Kung N, Evanoff BA, Perlmutter JS, Racette BA. Predictors of survival in patients with Parkinson disease. Arch Neurol 2012;69:601-607.